---
DrugClass: "[[Antidiabetic Drugs]]"
SubClass: "[[Dipeptidyl Peptidase-4 Inhibitors]]"
DrugClassAdverse: "[[Dipeptidyl Peptidase-4 Inhibitors#Adverse Reactions]]"
DrugClassContra: "[[Dipeptidyl Peptidase-4 Inhibitors#Contraindications]]"
BrandName: Onglyza
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "40"
KindleLinkChap: "[Chapter 40](kindle://book?action=open&asin=B09FRF11YJ&location=22730)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat:
---
```smiles
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Type 2 diabetes
2.5â€“ 5 mg orally daily

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Headache, upper [[Respiratory]] infection, urinary tract infection

### Interactions

`= this.ChemLink+this.file.name`

 